The authors concluded that along with the presence of psoriatic arthritis, studying HLA-C*06:02 could be of great help in seeking the best first-line treatment for psoriasis patients also supporting the hypothesis that HLA-C*06:02 positive patients may present a different endotype of psoriasis [51]. The gene discussed is HLA-C; the disease is psoriasis.